Aesthetic Medical International Holdings (AIH) stock price, revenue, and financials

Aesthetic Medical International Holdings market cap is $164 m, and annual revenue was ¥761.31 m in FY 2018

$164 M

AIH Mkt cap, 26-Feb-2020

¥212.2 M

Aesthetic Medical International Holdings Revenue Q2, 2019
Aesthetic Medical International Holdings Gross profit (Q2, 2019)145.3 M
Aesthetic Medical International Holdings Gross profit margin (Q2, 2019), %68.5%
Aesthetic Medical International Holdings Net income (Q2, 2019)57.5 M
Aesthetic Medical International Holdings Cash, 30-Jun-201978.7 M
Aesthetic Medical International Holdings EV464.6 M

Aesthetic Medical International Holdings Revenue

Aesthetic Medical International Holdings revenue was ¥761.31 m in FY, 2018 which is a 9.2% year over year increase from the previous period.

Embed Graph

Aesthetic Medical International Holdings Revenue Breakdown

Embed Graph

Aesthetic Medical International Holdings revenue breakdown by business segment: 9.7% from Non-surgical aesthetic medical services, 41.2% from Surgical aesthetic medical services and 49.0% from General healthcare services and other aesthetic medical services

Aesthetic Medical International Holdings Income Statement

Annual

CNYFY, 2016FY, 2017FY, 2018

Revenue

584.9m697.4m761.3m

Revenue growth, %

19%9%

Cost of goods sold

217.3m234.5m258.6m

Gross profit

367.5m462.9m502.7m

Gross profit Margin, %

63%66%66%

Sales and marketing expense

231.2m300.4m333.5m

General and administrative expense

121.8m92.8m115.5m

Operating expense total

353.0m393.2m449.0m

Interest expense

2.9m6.6m9.2m

Interest income

309.0k868.0k322.0k

Pre tax profit

64.2m(53.2m)(234.0m)

Income tax expense

13.7m19.3m18.5m

Net Income

5.1m(72.4m)(252.5m)

Quarterly

CNYQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

166.8m189.5m191.5m180.9m212.2m

Cost of goods sold

62.4m63.5m69.9m59.7m66.9m

Gross profit

104.4m126.0m121.6m121.2m145.3m

Gross profit Margin, %

63%67%64%67%68%

Sales and marketing expense

76.4m82.0m79.5m75.7m89.6m

General and administrative expense

21.9m30.5m25.4m28.3m38.0m

Operating expense total

98.3m112.5m104.9m104.0m127.6m

Pre tax profit

5.7m17.5m17.4m28.1m63.8m

Income tax expense

2.1m4.1m5.4m5.4m6.3m

Net Income

3.6m13.3m11.9m22.7m57.5m

Aesthetic Medical International Holdings Balance Sheet

Annual

CNYFY, 2017FY, 2018

Cash

105.3m101.9m

Accounts Receivable

10.0m10.8m

Inventories

25.0m21.1m

Current Assets

227.7m283.0m

PP&E

210.3m235.0m

Total Assets

578.0m676.5m

Accounts Payable

16.8m14.4m

Short-term debt

22.0m77.1m

Current Liabilities

133.5m171.3m

Long-term debt

85.4m90.5m

Non-Current Liabilities

466.8m754.6m

Total Debt

107.4m167.6m

Total Liabilities

600.2m925.9m

Common Stock

259.0k265.0k

Retained Earnings

(113.8m)(373.9m)

Total Equity

(22.2m)(249.4m)

Debt to Equity Ratio

-4.8 x-0.7 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

-26 x-2.7 x

Quarterly

CNYQ2, 2019

Cash

78.7m

Accounts Receivable

27.8m

Inventories

27.9m

Current Assets

213.3m

PP&E

497.3m

Total Assets

975.8m

Accounts Payable

18.0m

Short-term debt

105.4m

Current Liabilities

240.7m

Long-term debt

273.9m

Non-Current Liabilities

888.7m

Total Debt

379.3m

Total Liabilities

1.1b

Common Stock

306.0k

Retained Earnings

(297.2m)

Total Equity

(153.5m)

Debt to Equity Ratio

-2.5 x

Debt to Assets Ratio

0.4 x

Financial Leverage

-6.4 x

Aesthetic Medical International Holdings Cash Flow

Annual

CNYFY, 2016FY, 2017FY, 2018

Depreciation and Amortization

38.7m29.1m32.1m

Accounts Receivable

(2.8m)(4.2m)(824.0k)

Inventories

(110.0k)(11.0m)3.4m

Accounts Payable

3.9m2.7m(2.2m)

Cash From Operating Activities

57.6m97.8m29.9m

Purchases of PP&E

(38.6m)(47.5m)(45.5m)

Cash From Investing Activities

(38.9m)(69.2m)(76.2m)

Short-term Borrowings

(2.9m)(6.6m)(9.0m)

Long-term Borrowings

(65.2m)(57.9m)

Cash From Financing Activities

58.6m(28.2m)66.7m

Net Change in Cash

71.8m(20.4m)(4.5m)

Quarterly

CNYQ2, 2018Q2, 2019

Cash From Operating Activities

12.3m45.7m

Purchases of PP&E

(24.3m)(52.2m)

Cash From Investing Activities

(56.0m)(72.8m)

Short-term Borrowings

(4.2m)(5.9m)

Long-term Borrowings

(8.1m)47.0m

Cash From Financing Activities

18.7m4.0m

Net Change in Cash

(25.0m)(23.1m)

Aesthetic Medical International Holdings Ratios

CNYY, 2019

EV/CFO

10.2 x

Revenue/Employee

125.8k

Debt/Equity

-2.5 x

Debt/Assets

0.4 x

Financial Leverage

-6.4 x

Aesthetic Medical International Holdings Operating Metrics

FY, 2016FY, 2017Q2, 2018FY, 2018Q2, 2019

Average Spending per Non-surgical Procedure

¥2.40 k¥1.99 k¥1.51 k¥1.59 k¥1.36 k

Average Spending per Surgical Procedure

¥6.37 k¥7.06 k¥5.64 k¥4.94 k¥5.63 k

Doctors

117 130 206 187 203

Non-surgical Treatments

124.12 k166.63 k112.90 k235.37 k147.44 k

Surgical Treatments

27.34 k33.86 k24.53 k63.55 k27.98 k